DE69229110T2 - Monoklonarer antikörper gegen lps-kern - Google Patents

Monoklonarer antikörper gegen lps-kern

Info

Publication number
DE69229110T2
DE69229110T2 DE69229110T DE69229110T DE69229110T2 DE 69229110 T2 DE69229110 T2 DE 69229110T2 DE 69229110 T DE69229110 T DE 69229110T DE 69229110 T DE69229110 T DE 69229110T DE 69229110 T2 DE69229110 T2 DE 69229110T2
Authority
DE
Germany
Prior art keywords
thr
leu
tyr
arg
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69229110T
Other languages
English (en)
Other versions
DE69229110D1 (de
Inventor
Hermann Gram
Padova Franco Di
George Robin Barclay
Ian Poxton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Common Services Agency
Original Assignee
Common Services Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Common Services Agency filed Critical Common Services Agency
Application granted granted Critical
Publication of DE69229110D1 publication Critical patent/DE69229110D1/de
Publication of DE69229110T2 publication Critical patent/DE69229110T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69229110T 1991-03-13 1992-02-22 Monoklonarer antikörper gegen lps-kern Expired - Fee Related DE69229110T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919105292A GB9105292D0 (en) 1991-03-13 1991-03-13 Improvements in or relating to organic compounds
PCT/EP1992/000380 WO1992016624A1 (en) 1991-03-13 1992-02-22 Monoclonal antibody against lps core

Publications (2)

Publication Number Publication Date
DE69229110D1 DE69229110D1 (de) 1999-06-10
DE69229110T2 true DE69229110T2 (de) 1999-11-25

Family

ID=10691487

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229110T Expired - Fee Related DE69229110T2 (de) 1991-03-13 1992-02-22 Monoklonarer antikörper gegen lps-kern

Country Status (10)

Country Link
EP (1) EP0576439B1 (de)
JP (1) JP3328277B2 (de)
AT (1) ATE179753T1 (de)
AU (1) AU1261192A (de)
CA (1) CA2105979C (de)
DE (1) DE69229110T2 (de)
DK (1) DK0576439T3 (de)
ES (1) ES2131526T3 (de)
GB (1) GB9105292D0 (de)
WO (1) WO1992016624A1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741444B2 (en) 2002-07-04 2010-06-22 Patrys Limited Neoplasm specific antibodies and uses thereof
US8124080B2 (en) 2003-11-14 2012-02-28 Patrys Limited Human monoclonal antibody having fat-reducing effect
US8562995B2 (en) 2003-03-14 2013-10-22 Patrys Limited Neoplasm specific antibodies and uses thereof
US8741296B2 (en) 2003-11-14 2014-06-03 Patrys Limited Adenocarcinoma specific antibody SAM-6, and uses thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core
IL104782A0 (en) * 1992-02-19 1993-06-10 Schering Corp Cloning and expression of humanized monoclonal antibodies against human interleukin-4
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
CA3017477A1 (en) * 2009-04-27 2010-11-04 Immuron Limited Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
WO2012023051A2 (en) 2010-08-17 2012-02-23 Immuron Ltd. Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
DE102011006809A1 (de) 2011-04-05 2012-10-11 Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
CA3004790A1 (en) * 2015-11-10 2017-05-18 Visterra, Inc. Lipopolysaccharide binding antibody-antimicrobial peptide conjugates and uses thereof
US11890319B2 (en) 2017-01-18 2024-02-06 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
EP4126064A1 (de) 2020-04-03 2023-02-08 Visterra, Inc. Antikörpermolekül-wirkstoff-konjugate und verwendungen davon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU585200B2 (en) * 1983-05-06 1989-06-15 Velos Group Monoclonal antibodies reactive with endotoxin core
JPS61130300A (ja) * 1984-11-27 1986-06-18 ザ　ボ−ド　オブ　トラステイ−ズ　オブ　ザ　レランド　スタンフオ−ド　ジユニア　ユニバ−シテイ ヒトモノクロ−ナル抗体
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
FR2606421B1 (fr) * 1986-11-12 1990-01-26 Roussel Uclaf Anticorps monoclonaux antigram (-) procede de preparation et applications
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
WO1990003186A1 (en) * 1988-09-19 1990-04-05 Cetus Corporation Gram-negative bacterial endotoxin blocking monoclonal antibodies

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741444B2 (en) 2002-07-04 2010-06-22 Patrys Limited Neoplasm specific antibodies and uses thereof
US8562995B2 (en) 2003-03-14 2013-10-22 Patrys Limited Neoplasm specific antibodies and uses thereof
US8124080B2 (en) 2003-11-14 2012-02-28 Patrys Limited Human monoclonal antibody having fat-reducing effect
US8741296B2 (en) 2003-11-14 2014-06-03 Patrys Limited Adenocarcinoma specific antibody SAM-6, and uses thereof
US9273125B2 (en) 2003-11-14 2016-03-01 Patrys Limited Human monoclonal antibody having fat-reducing effect

Also Published As

Publication number Publication date
AU1261192A (en) 1992-10-21
DK0576439T3 (da) 1999-11-01
WO1992016624A1 (en) 1992-10-01
CA2105979A1 (en) 1992-09-14
ATE179753T1 (de) 1999-05-15
ES2131526T3 (es) 1999-08-01
JPH06505867A (ja) 1994-07-07
GB9105292D0 (en) 1991-04-24
JP3328277B2 (ja) 2002-09-24
EP0576439A1 (de) 1994-01-05
CA2105979C (en) 2003-05-13
DE69229110D1 (de) 1999-06-10
EP0576439B1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
DE69229110D1 (de) Monoklonarer antikörper gegen lps-kern
US6342587B1 (en) A33 antigen specific immunoglobulin products and uses thereof
CN106699891B (zh) 一种抗pd-l1抗体、其药物组合物及其用途
HRP20171292T1 (hr) Polipeptidi i konjugati klorotoksina i njihove uporabe
RU2017137010A (ru) Анти-сеасам6 антитела и их применения
KR970707160A (ko) 인체 인터루킨 5 수용체 알파-사슬에 대한 항체 (antibody against alpha-chain of human interleukin 5 receptor)
RU96115107A (ru) "очеловеченные" антитела и их использование
JP2018510636A5 (de)
EP1798243A3 (de) Ganglioside-assozierte rekombinante Antikörper und deren Gebrauch fuer Diagnose und Therapien von Tumoren
CY1113296T1 (el) Υβριδικο ανθρωπινο/τρωκτικου ιgg αντισωμα προς cd3 και μεθοδοι κατασκευης αυτου
JP6400480B2 (ja) ペプチドグリカン認識タンパク質１に結合する抗体
CN109762066A (zh) 4-1bb抗体及其制备方法和应用
US6346249B1 (en) Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products
JP2020521504A (ja) 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用
DE3485432D1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
CN107522783A (zh) 一种抗白介素17a 的抗体、其制备方法和应用
CN110461874B (zh) 抗gitr抗体、其抗原结合片段及其医药用途
CA2525657A1 (en) Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
US20230365679A1 (en) Anti-cd22 antibody molecule or antigen-binding fragment and use thereof
DE3685700T2 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
CN105061596B (zh) 人b淋巴细胞刺激因子的单克隆抗体及其应用
Muneta et al. Production of monoclonal antibodies to porcine interleukin-18 and their use for immunoaffinity purification of recombinant porcine interleukin-18
CN114957468A (zh) 一种抗Siglec15抗体及其用途
JP2020172543A (ja) 骨髄細胞で発現されるトリガー受容体１（ｔｒｅｍ−１）に結合し、それを遮断する抗体

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee